United States - English - NLM (National Library of Medicine)

strides pharma science limited - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), sodium bicarbonate (unii: 8mdf5v39qo) (sodium cation - unii:lyr4m0nh37, bicarbonate ion - unii:hn1zra3q20), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698) - polyethylene glycol 3350 420 g in 4 l - polyethylene glycol 3350, sodium chloride, sodium bicarbonate and potassium chloride for oral solution is indicated for bowel cleansing prior to colonoscopy in adults and pediatric patients aged 6 months or greater. polyethylene glycol 3350, sodium chloride, sodium bicarbonate and potassium chloride for oral solution is contraindicated in the following conditions: - gastrointestinal (gi) obstruction, ileus, or gastric retention - bowel perforation - toxic colitis or toxic megacolon - known allergy or hypersensitivity to any component of polyethylene glycol 3350, sodium chloride, sodium bicarbonate and potassium chloride for oral solution [see how supplied/storage and handling (16)] animal reproduction studies have not been conducted with polyethylene glycol 3350, sodium chloride, sodium bicarbonate and potassium chloride for oral solution. it is also not known whether polyethylene glycol 3350, sodium chloride, sodium bicarbonate and potassium chloride for oral solution can cause fetal harm when administered t

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

rebop holdings pty ltd - 2,4-d present as the ethyl/butyl esters - emulsifiable concentrate - 2,4-d present as the ethyl/butyl esters phenoxy acids-2,4-d-ester active 800.0 g/l - herbicide - aquatic areas weed control - see label | barley | caribbean stylo forage crop | caribbean stylo seed crop | cereal rye | fallow, - amaranth or amaranthus | apple-of-sodom | ball mustard | bathurst burr | black bindweed | black knapweed | boxthorn | buffalo burr | californian burr | californian thistle | caltrop - tribulis terrestis | camel or afghan melon | cape tulip | capeweed | cat's ears or flatweeds | charlock | clover | cockspur | colocynth | common plantain | common thornapple | corn gromwell, ironweed or sheepweed | cumbungi | dandelion - taraxacum officinale | deadnettle | dock | erodium, crowfoot or storksbill | fat hen | fumitory - red | fumitory - white | galvanised burr | golden thistle | goosefoot | groundsel | hemlock | hoary cress or whiteweed | horehound | horehound - seedling | ivy leaf speedwell | khaki weed | lesser swinecress or bittercress | lincoln weed, sand rocket or mustard | london rocket | lupins | melilotus or hexham scent | melon | mexican or prickly poppy | mignonette | mintweed | muskweed | mustard | nettle | new zealand spinach | nodding thistle | noogoora burr | nutgrass | onion weed | paddy melon - cucu

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

4 farmers australia pty ltd - 2,4-d present as the ethyl/butyl esters - emulsifiable concentrate - 2,4-d present as the ethyl/butyl esters phenoxy acids-2,4-d-ester active 800.0 g/l - herbicide - aquatic areas weed control - see label | barley | caribbean stylo forage crop | caribbean stylo seed crop | cereal rye | common - amaranth or amaranthus | apple-of-sodom | ball mustard | bathurst burr | black bindweed | black knapweed | boxthorn | buffalo burr | californian burr | californian thistle | caltrop or yellow vine | camel or afghan melon | cape tulip | capeweed | cat's ear or flatweed | charlock | clover | cockspur | colocynth | common thornapple | corn gromwell, ironweed or sheepweed | cumbungi | dandelion - taraxacum officinale | deadnettle | dock | erodium, crowfoot or storksbill | fat hen | fumitory - red | fumitory - white | galvanised burr | golden thistle | goosefoot | groundsel bush | hemlock | hoary cress or whiteweed | horehound | horehound - seedling | ivy leaf speedwell | khaki weed | lesser swinecress or bittercress | lincoln weed, sand rocket or mustard | london rocket | lupins | melilotus or hexham scent | mexican or prickly poppy | mignonette | mintweed | muskweed | mustard | nettle | new zealand spinach | nodding thistle | noogoora burr | nutgrass | onion weed | paddy melon - cucumis spp. | paterson's curse |

United States - English - NLM (National Library of Medicine)

accord healthcare inc. - methyldopa (unii: 56lh93261y) (methyldopa anhydrous - unii:m4r0h12f6m) - methyldopa anhydrous 125 mg - hypertension. methyldopa is contraindicated in patients: - with active hepatic disease, such as acute hepatitis and active cirrhosis. - with liver disorders previously associated with methyldopa therapy (see warnings ). - with hypersensitivity to any component of this product. - on therapy with monoamine oxidase (mao) inhibitors.

United States - English - NLM (National Library of Medicine)

mylan pharmaceuticals inc. - methyldopa (unii: 56lh93261y) (methyldopa anhydrous - unii:m4r0h12f6m) - methyldopa anhydrous 250 mg - hypertension. methyldopa is contraindicated in patients:

United States - English - NLM (National Library of Medicine)

mylan institutional inc. - methyldopa (unii: 56lh93261y) (methyldopa anhydrous - unii:m4r0h12f6m) - methyldopa anhydrous 500 mg - hypertension. methyldopa is contraindicated in patients: - with active hepatic disease, such as acute hepatitis and active cirrhosis. - with liver disorders previously associated with methyldopa therapy (see warnings). - with hypersensitivity to any component of this product. - on therapy with monoamine oxidase (mao) inhibitors.

United States - English - NLM (National Library of Medicine)

rebel distributors corp - methyldopa (unii: 56lh93261y) (methyldopa anhydrous - unii:m4r0h12f6m) - methyldopa anhydrous 250 mg - hypertension. methyldopa is contraindicated in patients: - with active hepatic disease, such as acute hepatitis and active cirrhosis. - with liver disorders previously associated with methyldopa therapy (see warnings ). - with hypersensitivity to any component of this product. - on therapy with monoamine oxidase (mao) inhibitors.

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - methyldopa (unii: 56lh93261y) (methyldopa - unii:56lh93261y) - methyldopa 250 mg - hypertension. methyldopa is contraindicated in patients: - with active hepatic disease, such as acute hepatitis and active cirrhosis. - with liver disorders previously associated with methyldopa therapy (see warnings ). - with hypersensitivity to any component of this product. - on therapy with monoamine oxidase (mao) inhibitors.

United States - English - NLM (National Library of Medicine)

mylan pharmaceuticals inc. - methyldopa (unii: 56lh93261y) (methyldopa anhydrous - unii:m4r0h12f6m), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - methyldopa anhydrous 250 mg - hypertension - (see box warning). methyldopa and hydrochlorothiazide tablets are contraindicated in patients:

United States - English - NLM (National Library of Medicine)

b. braun medical inc. - hydroxyethyl starch 130/0.4 (unii: 1gvo236s58) (hydroxyethyl starch 130/0.4 - unii:1gvo236s58), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698) - hydroxyethyl starch 130/0.4 6 g in 100 ml - 6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride injection is indicated for the treatment and prophylaxis of hypovolemia in adults and children. it is not a substitute for red blood cells or coagulation factors in plasma. - do not use hydroxyethyl starch (hes) products, including 6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride injection, in critically ill adult patients, including patients with sepsis, due to increased risk of mortality and renal replacement therapy (rrt).  - do not use hes products, including 6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride injection, in patients with severe liver disease. - do not use hes products, including 6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride injection, in patients with known hypersensitivity to hydroxyethyl starch [see general warnings and precautions (5.1) ] - do not use hes products in clinical conditions with volume overload.  - do not use hes products in patients with pre-existing coagulation or bleeding disorders.  - do not use h